Trump Admin. Investigating Reliance on Pharmaceuticals
President Trump has announced plans to impose new tariffs on imported semiconductors and pharmaceuticals, starting at 25% and potentially increasing over time.
Bill Adams, Chief U.S. Economist at Fifth Third Bank, breaks down the Fed's latest decision, inflation risks, and what Kevin Warsh's debut means for markets.
Lou Whiteman, Contributing Aerospace Analyst at The Motley Fool, discusses SpaceX's volatile first week of trading and what investors should watch next.